We are live on ! Find out more
ANIX icon

Anixa Biosciences

32 hedge funds and large institutions have $11.5M invested in Anixa Biosciences in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

100% more call options, than puts

Call options by funds: $118K | Put options by funds: $59K

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

10% more funds holding

Funds holding: 2932 (+3)

1.86% more ownership

Funds ownership: 8%9.86% (+1.9%)

3% less capital invested

Capital invested by funds: $11.8M → $11.5M (-$303K)

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
10
Reduced
4
Closed
5
Calls
$118K
Puts
$59K
Net Calls
+$59K
Net Calls Change
+$59K

ANIX Hedge Fund Activity: Q2 2021 in Review

32 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2021, worth a combined $11.5M — down 2.6% from $11.8M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ANIX positions and 5 closed out — a net gain of 3 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $530K. The largest seller was Jane Street, exiting entirely with an estimated $122K sold.

  • 32 institutional investors held Anixa Biosciences (ANIX) as of Q2 2021, up from 29 in Q1 2021.
  • Funds reported $11.5M of Anixa Biosciences stock for Q2 2021, down 2.6% quarter-over-quarter.
  • 8 funds opened new Anixa Biosciences positions in Q2 2021 and 5 closed out, a net change of +3 holders.
  • The largest Anixa Biosciences buyer in Q2 2021 was Renaissance Technologies, an estimated $530K added.
  • The largest Anixa Biosciences seller in Q2 2021 was Jane Street, an estimated $122K sold.

Based on aggregated 13F filings for Q2 2021.